These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30250913)

  • 1. EnABLing Cathepsin-Driven Melanoma Metastasis.
    Tripathi R; Plattner R
    Mol Cell Oncol; 2018; 5(4):e1458016. PubMed ID: 30250913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.
    Tripathi R; Fiore LS; Richards DL; Yang Y; Liu J; Wang C; Plattner R
    Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
    Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
    Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Vacuolar H
    Uhlman A; Folkers K; Liston J; Pancholi H; Hinton A
    Cancer Microenviron; 2017 Dec; 10(1-3):49-56. PubMed ID: 28766149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R; Casey SF
    Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
    Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
    Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment.
    Rousselet N; Mills L; Jean D; Tellez C; Bar-Eli M; Frade R
    Cancer Res; 2004 Jan; 64(1):146-51. PubMed ID: 14729618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.
    Jean D; Guillaume N; Frade R
    Biochem J; 2002 Jan; 361(Pt 1):173-84. PubMed ID: 11742542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.
    Tripathi R; Liu Z; Plattner R
    Curr Pharmacol Rep; 2018 Oct; 4(5):367-379. PubMed ID: 30746323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis.
    Gu JJ; Rouse C; Xu X; Wang J; Onaitis MW; Pendergast AM
    JCI Insight; 2016 Dec; 1(21):e89647. PubMed ID: 28018973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.
    Schwenck J; Maurer A; Fehrenbacher B; Mehling R; Knopf P; Mucha N; Haupt D; Fuchs K; Griessinger CM; Bukala D; Holstein J; Schaller M; Menendez IG; Ghoreschi K; Quintanilla-Martinez L; Gütschow M; Laufer S; Reinheckel T; Röcken M; Kalbacher H; Pichler BJ; Kneilling M
    Theranostics; 2019; 9(13):3903-3917. PubMed ID: 31281521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of microglial cathepsins in neurodegenerative disease.
    Lowry JR; Klegeris A
    Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis.
    Husmann K; Muff R; Bolander ME; Sarkar G; Born W; Fuchs B
    Mol Carcinog; 2008 Jan; 47(1):66-73. PubMed ID: 17683065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.
    Guillaume-Rousselet N; Jean D; Frade R
    Biochem J; 2002 Oct; 367(Pt 1):219-27. PubMed ID: 12241546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin L increases invasion and migration of B16 melanoma.
    Yang Z; Cox JL
    Cancer Cell Int; 2007 May; 7():8. PubMed ID: 17488522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
    Fröhlich E; Möhrle M; Klessen C
    Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.
    Corvo I; Cancela M; Cappetta M; Pi-Denis N; Tort JF; Roche L
    Mol Biochem Parasitol; 2009 Sep; 167(1):41-7. PubMed ID: 19383516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.